Baker Hughes Co vs Medpace Holdings Inc — how do they compare? Baker Hughes Co trades at $64.7 (market cap $64.34B), while Medpace Holdings Inc trades at $607 (market cap $16.90B). The key difference: Baker Hughes Co is far larger — about 3.8× Medpace Holdings Inc's market cap, and Baker Hughes Co pays a 1.42% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| BKR | MEDP | |
|---|---|---|
Market Cap | $64.34B | $16.90B |
Sector | Energy | Technology |
52-Week High | $69.67 | $620.59 |
52-Week Low | $42.51 | $393.42 |
Enterprise Value | $64.86B | $16.52B |
Dividend Yield | 1.42% | — |
Trailing returns across standard periods
Latest headlines on both assets
Baker Hughes is a global leader in oilfield services and oilfield equipment, with particularly strong presences in the artificial lift, specialty chemicals, and completions markets. The other half of its business focuses on industrial power generation, process solutions, and industrial asset management, with high exposure to the liquid natural gas market specifically, as well as broader industrials end markets.
Read more on BKR →Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →